BayCare Health System is no stranger to the opioid and prescription drug crisis that has claimed thousands of lives across the United States in recent years.
They developed an internal dashboard that used analytics to identify both at-risk patients and providers who might be inadvertently contributing to the crisis through their prescribing behaviors.
The dashboard allows leaders to discuss the issue of opioid and benzodiazepine addiction with clinicians and how they can prescribe more accurately to patient needs, both inpatient and outpatient.
“Before the dashboard, we really didn’t know which providers were prescribing too many controlled substances or which patients were at risk of overdoses,” said Dr. Alan M. Weiss, vice president and CMIO of Baycare, who is due to speak about his work this Tuesday at HIMSS22. “Analysis was the key to solving this challenge.”
He explained that the dashboard quickly identifies providers who prescribe more controlled substances than their peers in the same specialty, which he called a key finding.
For example, the use of opioids is different in orthopedic surgery than in pediatrics. This means that it was very important to keep things on a specialized analytical side.
Similarly, BayCare has also used analytics to identify patients who have received more prescriptions from multiple providers or whose milliequivalents of morphine put them at risk of overdose.
“We also included analyzes that allowed us to take opioids and benzodiazepines and find patients who were taking both,” Weiss said. “When you take both, it increases your risk of overdose by 10 times, so being able to get this information and find it quickly was key to our analytical solution.”
He explained that another key aspect of the job involves the ability to subscribe to the dashboard.
“Our clinician leaders are so busy and overwhelmed with so many dashboards and data analyzes that it’s hard for them to keep up,” he said. “By subscribing to their favorite dashboard view, they received data exactly how they wanted it to appear.”
The group that developed the dashboard tools involved people from across the organization, including vendors representative of the ambulatory, emergency, and inpatient fields and included specialties from family medicine, d emergency and hospital medicine.
Additionally, the medical informatics team was deeply involved, as were the pharmacists in our corporate data warehouse and analytics team.
“It was difficult to create a unified approach and decide how we were going to display information in a way that visually allowed people to quickly see that providers were the patients they needed to care for,” he said. declared. “At the same time, as our efforts progressed, the power of the tool was more and more excited.”
Weiss’ HIMSS22 session, “Reducing Controlled Substance Prescriptions via Dashboard Tool,” is scheduled for Tuesday, March 15 from 1:30-2:30 p.m. in room WF3.